Repligen Imaging Aid SecreFlo May Provide Pancreatitis Patients An Endoscopy Alternative

A second read of Phase III data revealed statistically significant improvement in MRIs of pancreatitis patients for Repligen’s imaging aid SecreFlo. That finding will be tested by FDA’s Gastrointestinal Drugs Advisory Committee May 31.